Pharma Journalist 8887 posts 0 comments

iRegene Therapeutics has reached a major regulatory milestone with its lead program for Parkinson’s disease, as the U.S. Food and Drug Administration granted Regenerative Medicine…
Read More...

Novartis has received a significant regulatory boost for its autoimmune disease pipeline after the U.S. Food and Drug Administration granted Breakthrough Therapy designation to…
Read More...

AstraZeneca has acquired Modella AI, a life sciences–focused artificial intelligence company, in a move that deepens the companies’ existing collaboration and strengthens AstraZeneca’s…
Read More...

Agenus Inc. has completed the closing of its previously announced strategic collaboration with Zydus Lifesciences Ltd., a move aimed at accelerating the global development and potential…
Read More...

The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have jointly agreed on ten principles for good artificial intelligence (AI) practice across the…
Read More...

InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing agreement aimed at developing a differentiated small-molecule therapy…
Read More...

Illumina has unveiled what it calls the world’s largest genome-wide genetic perturbation dataset, a major initiative designed to accelerate artificial intelligence–driven drug discovery…
Read More...

SciNeuro Pharmaceuticals has entered into a worldwide licensing and collaboration agreement with Novartis Pharma AG to advance a novel antibody program for the treatment of Alzheimer’s…
Read More...

NVIDIA and Eli Lilly and Company have announced the creation of a first-of-its-kind AI co-innovation lab designed to apply artificial intelligence to some of the most persistent…
Read More...

Atara Biotherapeutics has received a setback in its efforts to bring EBVALLO™ (tabelecleucel) to patients with Epstein-Barr virus–positive post-transplant lymphoproliferative disease…
Read More...